Monica Coenraads

Executive Director
Rett Syndrome Research Trust

Monica Coenraads’ involvement with Rett syndrome began the day her then-2-year-old daughter was diagnosed with the disorder. A year later, in 1999, she co-founded the Rett Syndrome Research Foundation (RSRF) and held the position of scientific director during the eight years of the foundation’s drive to stimulate scientific interest and research in Rett syndrome. This culminated in the groundbreaking work in 2007 that demonstrated the first global reversal of symptoms in preclinical models of the disorder. Coenraads co-founded the Rett Syndrome Research Trust (RSRT) in late 2007 to pursue the next steps from that milestone. Under her leadership at RSRF and RSRT, $36 million has been raised for research. In 2010 she co-founded the Rett Syndrome Research Trust UK, now called Reverse Rett, and currently serves as a trustee.

Explore more from The Transmitter

Portrait of Raphe Bernier in front of a collage of a building, a chalkboard, a computer and human silhouettes.

Frameshift: Raphe Bernier followed his heart out of academia, then made his way back again

After a clinical research career, an interlude at Apple and four months in early retirement, Raphe Bernier found joy in teaching.

By Katie Moisse
20 February 2026 | 8 min read
Research image showing gene association.

Organoid study reveals shared brain pathways across autism-linked variants

The genetic variants initially affect brain development in unique ways, but over time they converge on common molecular pathways.

By Giorgia Guglielmi
19 February 2026 | 4 min read
Mouse father with pups.

Single gene sways caregiving circuits, behavior in male mice

Brain levels of the agouti gene determine whether African striped mice are doting fathers—or infanticidal ones.

By Natalia Mesa
18 February 2026 | 6 min read

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.